The Independent Specialty Pharmacy Coalition (ISPC) is an advocacy organization comprised of a number of the leading national and regional specialty pharmacy companies across the country.
Formed in 2010, the ISPC is uniquely positioned to fight for the causes and challenges facing specialty pharmacies today. Our leaders are experts in both specialty pharmacy issues as well as health policy lobbying and utilize their knowledge and experience to give independent specialty pharmacies a strong voice. The ISPC works diligently to represent its members before Congress and seeks to rally support behind the pressing needs of the specialty pharmacy community.
February 20, 2016, New York Times, Break Up The Insulin Racket
January 22, 2016, The Lund Report, Pharmacists Push for Better Regulations to Keep PBMS Honest
January 14, 2016, Bloomberg, Express Scripts Accused of Overcharging Anthem by $3 Billion per year
December 30, Minn/St Paul Business Journal, Lawsuit: Prime Therapeutics' Reimbursement Plan is Costing CVS $100M Per Year
November 23, 2015, Pharmacy Times,PBMs Scrutinized for LTC Pharmacy Payment Practices
November 20, 2015, Barron's, Express Scripts' Unit Supports High-Priced Specialty Drugs
November 19, 2015, KARE11, What's the real cost of prescription drugs?
October 23, 2015, Law360.com,
Medco Defrauded Government Health Insurance Programs, Suit Says (click here for a copy of the complaint)
October 22, Wilson County News,Greed Sickens Patients and Drives up Health Costs
October 9, 2015, Daily Democrat, Pharmacy Benefit Managers Make Money by Denying Care
August 13, 2015, Arkansas AG Press Release, Rutledge Announces Settlement with Accredo Pharmacy(owned by Express Scripts)
July 15, 2015, New York Times, Specialty Pharmacies Proliferate, Along With Questions
May 20, 2015, NASDAQ, Medco Health Solutions to Pay $7.9 Mln to Resolve Kickback Allegations
May 13, 2015, Reuters, CVS Pays $22 million to Resolve Florida Painkiller Probe
May 1, 2015, Wall Street Journal,Express Scripts to Pay $60M to Settle Novartis Kickback Scheme
February 12, 2015, Los Angeles Times, With Purchase of EnvisionRx, Rite-Aid Gets in on the Drug Intermediary Racket
February 11, 2015, Wall Street Journal,AstraZeneca Pays $7.9M to Settle Kickback Charges Paid to a PBM
January 15 , 2015, St. Louis Business Journal, Express Scripts Facing Antitrust, Contract Complaint